- Home
- GILD vs MU Comparison
GILD vs MU Comparison
Compare GILD & MU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GILD
- MU
- Stock Information
- Founded
- GILD 1987
- MU 1978
- Country
- GILD United States
- MU United States
- Employees
- GILD N/A
- MU 43000
- Industry
- GILD Biotechnology: Biological Products (No Diagnostic Substances)
- MU Semiconductors
- Sector
- GILD Health Care
- MU Technology
- Exchange
- GILD Nasdaq
- MU Nasdaq
- Market Cap
- GILD 110.9B
- MU 107.9B
- IPO Year
- GILD 1992
- MU N/A
- Fundamental
- Price
- GILD $88.46
- MU $97.51
- Analyst Decision
- GILD Buy
- MU Strong Buy
- Analyst Count
- GILD 24
- MU 26
- Target Price
- GILD $93.91
- MU $146.28
- AVG Volume (30 Days)
- GILD 7.3M
- MU 15.2M
- Earning Date
- GILD 11-06-2024
- MU 12-18-2024
- Dividend Yield
- GILD 3.48%
- MU 0.47%
- EPS Growth
- GILD N/A
- MU N/A
- EPS
- GILD 0.10
- MU 0.70
- Revenue
- GILD $28,299,000,000.00
- MU $25,111,000,000.00
- Revenue This Year
- GILD $5.71
- MU $56.72
- Revenue Next Year
- GILD $0.37
- MU $19.66
- P/E Ratio
- GILD $911.55
- MU $139.30
- Revenue Growth
- GILD 3.31
- MU 61.59
- 52 Week Low
- GILD $62.07
- MU $72.93
- 52 Week High
- GILD $98.90
- MU $157.54
- Technical
- Relative Strength Index (RSI)
- GILD 46.13
- MU 40.68
- Support Level
- GILD $89.01
- MU $99.07
- Resistance Level
- GILD $98.90
- MU $114.30
- Average True Range (ATR)
- GILD 2.11
- MU 3.29
- MACD
- GILD -0.63
- MU -1.44
- Stochastic Oscillator
- GILD 8.58
- MU 10.55
About GILD Gilead Sciences Inc.
Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. The acquisitions of Corus Pharma, Myogen, CV Therapeutics, Arresto Biosciences, and Calistoga have broadened this focus to include pulmonary and cardiovascular diseases and cancer. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of combination drug Harvoni, and the Kite, Forty Seven, and Immunomedics acquisitions boost Gilead's exposure to cell therapy and noncell therapy in oncology.
About MU Micron Technology Inc.
Micron is one of the largest semiconductor companies in the world, specializing in memory and storage chips. Its primary revenue stream comes from dynamic random access memory, or DRAM, and it also has minority exposure to not-and or NAND, flash chips. Micron serves a global customer base, selling chips into data centers, mobile phones, consumer electronics, and industrial and automotive applications. The firm is vertically integrated.